Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ: ASTH ) with a Buy and raises the price target from $47 to $55.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.